Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis

精神分裂症(面向对象编程) 奥氮平 阿立哌唑 抗精神病药 体重增加 随机对照试验 荟萃分析 精神科 医学 心理信息 梅德林 不利影响 严格标准化平均差 鲁拉西酮 体重 内科学 法学 政治学
作者
Michel Sabé,Konstantinos Pallis,Marco Solmi,Alessio Crippa,Othman Sentissi,Stefan Kaiser
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:84 (2) 被引量:70
标识
DOI:10.4088/jcp.22r14490
摘要

To investigate the association of metabolic side effects with antipsychotic dose, we conducted a dose-response meta-analysis of randomized controlled trials (RCTs) in which antipsychotics were administered to people with schizophrenia. The primary outcome was mean change in weight. The secondary outcomes were the mean changes in metabolic parameters. MEDLINE, Embase, PubMed, PsyARTICLES, PsycINFO, Cochrane Database of Systematic Reviews, and different trial registries were searched for articles published in English until February 2021. We identified fixed-dose RCTs with first- or second-generation antipsychotics. The quality of RCTs was measured with Cochrane's Risk of Bias tool. We performed a dose-response meta-analysis. We retained 52 RCTs including 22,588 participants. With the exception of aripiprazole long-acting injectable (LAI), all investigated antipsychotics presented significant dose-response associations with weight, from lurasidone with a quasi-parabolic shaped curve (9 studies, estimation of 95% effective dose [ED95; 59.93 mg/d] = 0.53 kg/6 wk) to olanzapine LAI with a curve that continued to increase with the dose (1 study, ED95 [15.05 mg/d] = 4.29 kg/8 wk). All curves could be ordered in 3 different classes of shapes-quasi-parabolic, plateau, and ascending. We found significant dose-response associations for weight and metabolic variables, with a unique signature for each antipsychotic. Weight gain can occur at a relatively low median effective dose, and increasing doses can be associated with greater weight gain for some drugs. Despite several limitations, including the limited number of available studies, our results may provide useful information for preventing weight gain and metabolic disturbance by adapting antipsychotic doses. PROSPERO ID number CRD42021176569.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
科研通AI6.4的应助被zhou采纳,获得10
2秒前
科研通AI6.3的应助被幸运鹅采纳,获得10
3秒前
于十Zzzz完成签到 ,获得积分10
3秒前
3秒前
3秒前
3秒前
小王小王发布了新的文献求助10
4秒前
4秒前
Harry发布了新的文献求助20
5秒前
田様的应助被冲冲采纳,获得10
7秒前
8秒前
www的应助被山海不远采纳,获得10
8秒前
9秒前
刘亦菲完成签到,获得积分10
9秒前
Little_可爱发布了新的文献求助10
10秒前
11秒前
科研通AI6.4的应助被zx采纳,获得10
11秒前
大太阳完成签到 ,获得积分10
11秒前
molihuakai的应助被6yy采纳,获得30
11秒前
丘比特的应助被Run采纳,获得10
11秒前
13秒前
Hello的应助被笙笙采纳,获得10
13秒前
蓝色雨完成签到,获得积分10
14秒前
14秒前
领导范儿的应助被心想事成采纳,获得10
15秒前
心房子完成签到,获得积分10
15秒前
15秒前
koukaki完成签到,获得积分10
16秒前
犹豫访天完成签到,获得积分10
16秒前
Little_可爱完成签到,获得积分10
16秒前
16秒前
Lemonhead的应助被HHHHHH采纳,获得30
17秒前
18秒前
AN发布了新的文献求助10
18秒前
OK发布了新的文献求助10
18秒前
19秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177767
求助须知:如何正确求助?哪些是违规求助? 9568590
关于积分的说明 21799821
捐赠科研通 7772374
什么是DOI,文献DOI怎么找? 3432476
关于科研通互助平台的介绍 2556695
邀请新用户注册赠送积分活动 2478034